Shing-shing Yeh, MD


  • Professor, Department of Medicine

Board Certification

  • Internal Medicine - Geriatric Medicine
  • Internal Medicine

Training

Medical School
  • University of Miami, School of Medicine, Miami, FL
Residency Training
  • Cambridge city hospital, Salem Hospital MA

Specialty

  • Internal Medicine

Subspecialty

  • General Medicine and Geriatrics

Clinical Interests/Expertise

  • Geriatrics

Research Interests/Expertise

  • Weight Loss
  • Cachexia
  • Nutrition
  • Dementia
  • Women's Health
No Image

Contact Information

Northport VAMC
79 Middle Ville Road,
Northport, NY 11768.

Telephone Ph.: 631-261-4400
Fax Fax: 631-266-6030





  • Personal Statement
  • Honors
  • Publications
  • Grants/Trials

  • Dr. Yeh has published many papers on a variety of topics in geriatric, including the treatment of geriatric weight loss, cytokines in cachexia, risk factors relating to inflammation and nutrition survival among cachectic geriatric patients. She was also an investigator for the landmark VA Cooperative Trial of the herpes zoster vaccine in older adults - the Shingles Prevention Study- which led to the FDA approval of the vaccine.

  • American Geriatrics Society Recognition Award, 2001
  • NIH Training Grant, Biochemistry Department, Dartmouth Medical School, 1977-1982
  • Class Valedictorian, National Taiwan Normal University, 1976

  • For articles published by Dr. Hensley, click here.

  • HT-ANAM-303 Anamorelin HCL in the treatment of Non-small Cell lung Cancer Cachexia (NSCLC-C) - An Extension Study of HT-ANAM-301, 2012
  • HT-ANAM-301 Anamorelin HCL in the treatment of Non-small Cell lung Cancer Cachexia (NSCLC-C), 2012
  • TRAIL: Evaluate the Effects of Propranolol in Combination with an NSAID (Etodolac) on Protein metabolism and Inflammatory Markers in Subjects Diagnosed with Metastatic Cancer (Vicus company), 2006
  • GRANT: “The Anemia of Chronic Disease in Geriatric patients” (CAFÉ study), 2006
  • GRANT: “VA Cooperative study CSF 403B.” Amendment 8: Trial of Varicella-Zoster Vaccine for the Prevention of Herpes Zoster and its Complications, 2005-2007
  • CSP: Enhancing the Quality of Informed Consent - Development Phase (EQUIC-DP) – A Sub-study of the CSP 403 the Shingles Prevention Study.
    CSP # 476: Enhancing the Quality of Informed Consent - Self Monitoring ( EQUIC- SM) parent study
    CSP #476: EQUIC-SM; Parent Study CSP # 499 – SELECT Study
    CSP #799a: Aging Cohort to Improve Veteran's Health (ACTIVE), 2001-2004
  • GRANT: Part of a multicenter VA Cooperative study (with the Southwest Oncology Group) to prevent prostate cancer: “The Selenium and Vitamin E Chemoprevention Trial (SELECT)” CSP # 499, 2001
  • GRANT: Part of a VA Cooperative study. CSF 403: Trial of Varicella-Zoster Vaccine for the Prevention of Herpes Zoster and its Complications, 1999-2006
  • GRANT: A multicenter study: “Randomized, double –blind, placebo-controlled dose-ranging clinical trial of the efficacy and safety of oxandrolone in increasing respiratory muscle strength of patients with chronic obstructive pulmonary disease associated weight loss” ( Bio-Technology General Corp.), 1999
  • GRANT: “A double-blind, randomized placebo-controlled trial of megestrol acetate in underweight dialysis patients” (Bristol-Myers Squibb), 1999
  • GRANT: "An open-label valuation of the effects of oxandrolone on body weight and composition in patients with chronic obstructive pulmonary disease and associated involuntary weight loss” ( Bio-Technology General Corp.), 1998
  • GRANT: A pilot study Megestrol Acetate suspension Therapy in Geriatric Cachexia (Bristol- Myers Squibb), 1996